eledon-logo-1230.png
Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy
09 mai 2022 08h00 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
eledon-logo-1230.png
Eledon Pharmaceuticals to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
05 mai 2022 16h05 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., May 05, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
eledon-logo-1230.png
Eledon Pharmaceuticals to Participate in LifeSci Partners Immunology & Inflammation Symposium
03 mai 2022 16h05 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
eledon-logo-1230.png
Eledon Pharmaceuticals to Participate in 18th Annual Noble Capital Markets Investor Conference
18 avr. 2022 16h05 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
eledon-logo-1230.png
Eledon to Host Virtual R&D Day on Thursday, April 28, 2022
14 avr. 2022 16h05 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
MeGO Confidence Delivered Logo Teal.png
MediGO’s Much-Anticipated Supply Chain Offering Innovates Organ Donation and Transplantation to Save More Lives
07 avr. 2022 16h12 HE | MediGO
BALTIMORE, Md., April 07, 2022 (GLOBE NEWSWIRE) -- MediGO, known for its Scoutline™ logistics platform that enables real-time management of time-sensitive medical resources on a centralized...
TIP_link_300x300.jpg
Organ Care Products Market Size Worth $272.16 Mn, Globally, by 2028 at 15.6% CAGR - Exclusive Report by The Insight Partners
29 mars 2022 05h30 HE | The Insight Partners
New York, March 29, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Organ Care Products Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality...
eledon-logo-1230.png
Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
24 mars 2022 16h01 HE | Eledon Pharmaceuticals, Inc.
Topline data from Phase 2a trial of tegoprubart in ALS expected in 2Q 2022 Ongoing clinical studies evaluating tegoprubart in kidney transplantation, IgA nephropathy, and islet cell transplantation...
eledon-logo-1230.png
Eledon Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results on Thursday, March 24, 2022
17 mars 2022 08h00 HE | Eledon Pharmaceuticals, Inc.
IRVINE, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of...
American Kidney Fund
American Kidney Fund Awards Two Clinical Scientist in Nephrology Fellowships to Researchers Focused on Disparities in Kidney Transplants, Genetic Variants in Nephrotic Syndrome
10 mars 2022 10h00 HE | American Kidney Fund
ROCKVILLE, Md., March 10, 2022 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced the 2022 funding recipients through its Clinical Scientist in Nephrology Program, which seeks to...